We work at the convergence of science, medicine, and engineering to reinvent the process of drug discovery and treatment.

The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.


The program’s faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research and computer science to accelerate the invention of life-saving medicines and the precision diagnostics needed to optimally treat individual patients. Our program brings together two approaches: Systems Pharmacology provides a powerful means to study the changes that promote disease and the ways in which therapeutic drugs function at a molecular level. Regulatory science focuses on the evaluation of drugs in clinical trials and on balancing the benefits and risks of new medicines.


Learn about our components:

News, Events, & Updates

Innovators in Therapeutics Speaker Series

Dr. David Altshuler, Executive VP, Global Research & CSO, Vertex Pharmaceuticals

March 24, 12:00pm ET

Register here!

“New 3D Atlas of Colorectal Cancer Promises Improved Diagnosis, Treatment”

NIH Director’s Blog | January 31, 2023

Read the article

2022 Global Conference on Regulatory Science Proceedings Available

Read the Proceedings